Verastem (VSTM) Interest Coverage Ratio (QoQ) (2012 - 2026)
Verastem (VSTM) Interest Coverage Ratio (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.46% |
| Dec 31, 2025 | -1,064.23% |
| Sep 30, 2025 | -115.94% |
| Jun 30, 2025 | 89.27% |
| Mar 31, 2025 | -34.44% |
| Dec 31, 2024 | 14.54% |
| Sep 30, 2024 | -100.84% |
| Jun 30, 2024 | -159.81% |
| Mar 31, 2024 | 93.21% |
| Dec 31, 2023 | -382.40% |
| Sep 30, 2023 | -4.27% |
| Jun 30, 2023 | 28.04% |
| Mar 31, 2023 | -8.11% |
| Dec 31, 2022 | -2.09% |
| Sep 30, 2022 | 31.84% |
| Jun 30, 2022 | 49.39% |
| Mar 31, 2022 | 96.00% |
| Dec 31, 2021 | -112,672.15% |
| Sep 30, 2021 | -73.43% |
| Jun 30, 2021 | 65.90% |